Jerry Holubec, DO
General Practice · Keller, TXNPI 1831169895
Payments from drug & device makers
Across 49 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arbor Pharmaceuticals, Inc.$309
- Medtronic$147
- Biohaven Pharmaceuticals, Inc.$69
- Novartis$49
- Redhill Biopharma Inc.$44
- Azurity Pharmaceuticals, Inc.$32
- plus $125 from 6 others
What the payments were for
- Food & beverage$775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arbor Pharmaceuticals, Inc. | 21 | $309 |
| Medtronic(2 entities) | 11 | $147 |
| Biohaven Pharmaceuticals, Inc. | 4 | $69 |
| Novartis | 2 | $49 |
| Redhill Biopharma Inc. | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Boston Scientific | 2 | $29 |
| AbbVie | 1 | $25 |
| Averitas Pharma Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Avanos Medical | 1 | $13 |
How this compares
$775 in reported general payments places this provider in the 75th percentile of 8,074 general practice providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 162 | $4,579 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $2,023 |
| Hydromorphone Hcl | 46 | $1,903 |
| Fentanyl | 17 | $1,677 |
| Gabapentin | 60 | $1,025 |
| Oxycodone Hcl | 46 | $761 |
| Methadone Hcl | 15 | $596 |
| Tizanidine Hcl | 41 | $457 |
| Methocarbamol | 29 | $316 |
| Promethazine Hcl | 18 | $167 |
| Cyclobenzaprine Hcl | 17 | $88 |
| Tramadol Hcl | 18 | $84 |
| Trazodone Hcl | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other general practice in Keller
- Olusoji AfuwapeDallas$12.3M
- Karen CummingsPlano$8.4M
- Helen ShpatsHouston$3.3M
- Kelechi AzuoguHouston$2.5M
- Marcus LastimadoFort Bliss$2.3M
- Christina DeanFrisco$1.9M
- Paul ShrodeMissouri City$1.2M
- Sheila SchmidtPearland$811K
- Danielle CoulterSan Antonio$681K
- Alan DouglasSan Antonio$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.